Asia-Pacific Medical Cannabis Market, By Product (Oil, Medical Cannabis Capsules, Patch, Whole Flower, Ground Flower, Vape Pen, Dried Medical Cannabis, Creams & Moisturizer, Masks & Serum, Cleanser, and Others), Source (Natural and Synthetic), Species (Cannabis Indica, Sativa, and Hybrid), Application (Alzheimer’s Disease, Appetite Loss, Cancer, Inflammatory Bowel Diseases, Eating Disorders, Epilepsy, Autism, Mental Health Conditions, Multiple Sclerosis, Pain Management, Nausea, Muscle Spasms, Wasting Syndrome (Cachexia), Elevate Mood, Depression and Sleep Disorders, Anxiety, and Others), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC)/ Delta-8-Tetrahydrocannabinol, Cannabinol (CBN), Cannabicyclol (CBL), Cannabichromene (CBC), Cannabigerol (CBG), and Others), Treatment Type (Expectorant, Antiviral, Analgesic, Aphrodisiac, Psychedelic, and Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others), End User (Pharmaceutical Industry, Research and Development Centers, Homecare Setting, Hospital, Rehab Centers, and Others), Distribution Channel (B2B and B2C) - Industry Trends and Forecast to 2030.
Asia-Pacific Medical Cannabis Market Analysis and Insights
The rising number of patients related to chronic diseases Asia-Pacific and an increased inclination towards a healthy lifestyle are some of the factors that are expected to drive market growth. In addition, the rise in the number of product approvals and increasing R&D activities for medical cannabis devices are expected to drive market growth. However, the high cost of medical cannabis devices and procedures, medicinal drugs, safety concerns and adverse effects associated with laser procedures, and lack of awareness about the treatment from laser devices are expected to restrain the market growth. Additional technological advancements in medical cannabis and strategic initiatives by emerging players are expected to act as opportunities for market growth. However, stringent regulations and a lack of skilled professionals are expected to pose a challenge to market growth.
The use of cannabis as medicine is not rigorously tested due to government restrictions and resulting in limited clinical research to define the efficacy of cannabis in medical and clinical applications. However, preliminary studies suggest that cannabis reduces vomiting and nausea in chemotherapy patients and helps in increasing appetite.
Data Bridge Market Research analyzes that the Asia-Pacific medical cannabis market is expected to grow at a CAGR of 22.3% during the forecast period of 2023 to 2030.
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Year |
2021 (Customizable to 2015 – 2020) |
|
Quantitative Units |
Revenue in USD Million |
|
Segments Covered |
Product (Oil, Medical Cannabis Capsules, Patch, Whole Flower, Ground Flower, Vape Pen, Dried Medical Cannabis, Creams & Moisturizer, Masks & Serum, Cleanser, and Others), Source (Natural and Synthetic), Species (Cannabis Indica, Sativa, and Hybrid), Application (Alzheimer’s Disease, Appetite Loss, Cancer, Inflammatory Bowel Diseases, Eating Disorders, Epilepsy, Autism, Mental Health Conditions, Multiple Sclerosis, Pain Management, Nausea, Muscle Spasms, Wasting Syndrome (Cachexia), Elevate Mood, Depression and Sleep Disorders, Anxiety, and Others), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC)/ Delta-8-Tetrahydrocannabinol, Cannabinol (CBN), Cannabicyclol (CBL), Cannabichromene (CBC), Cannabigerol (CBG), and Others), Treatment Type (Expectorant, Antiviral, Analgesic, Aphrodisiac, Psychedelic, and Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others), End User (Pharmaceutical Industry, Research and Development Centers, Homecare Setting, Hospital, Rehab Centers, and Others), Distribution Channel (B2B and B2C) |
|
Countries Covered |
Australia, Thailand, South Korea, Japan, China, New Zealand, Singapore, India, Taiwan, Malaysia, Philippines, and Rest of Asia-Pacific |
|
Market Players Covered |
MediPharm Labs Inc., Tilray, Aurora Cannabis, JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc), HEXO Corp. (Zenabis Asia-Pacific Ltd), Cresco Labs, Peace Naturals Project Inc., CANOPY GROWTH CORPORATION, Medical Marijuana, Inc., Seed Cellar, EcoGen Biosciences, CANNABIS SEEDS USA, Seeds For Me, HUMBOLDT SEED COMPANY, Extractas, World Class Cannabis Seeds (Crop King Seeds), BARNEY'S FARM, FOLIUM BIOSCIENCES, PharmaHemp, Elixinol Asia-Pacific Limited, ENDOCA, Harmony, MARY’S nutritionals, LLC, Pure Ratios, Greenwich Biosciences, Inc., Upstate Elevator Supply Co., Apothecanna, BOL Pharma, and IDT Australia among others |
Market Definition
Cannabis is a psychoactive drug that is derived from the cannabis plant of the Cannabaceae family. For several years, it has been used medicinally and has a wide range of applications in the treatment of various diseases including chronic pain, cancer, depression, diabetes, arthritis, glaucoma, epilepsy, migraines, AIDS, and Alzheimer’s among others.
The increased medicinal use of cannabis, the controlled legalization and use of cannabis in various industries, and the advanced methodologies present in the field are some of the factors expected to drive market growth.
Asia-Pacific Medical Cannabis Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail as below:
Drivers
- Increased use of cannabis in medicines
Medicinal cannabis is derived from cannabis plants and can be used to treat symptoms of certain medical conditions, and the side effects of some treatments. The most common form of medicinal use of cannabis is pain management. There has been gradual acceptance and use of medicinal cannabis with the growing number of countries that have legalized the use of cannabis for various indications. Medical cannabis has been approved for use by the FDA for three indications which are rare and severe forms of epilepsy, Dravet syndrome, and Lennox-Gastaut syndrome and also to treat the spasticity in Multiple Sclerosis (MS).
Medical marijuana uses the marijuana plant or chemicals in it to treat diseases or conditions apart from the approved drugs, there is an increased interest in two cannabinoids which are delta-9-tetrahydrocannabinol and cannabidiol. Tetrahydrocannabinol is shown to improve appetite, minimize fatigue, and manage muscle function issues while cannabidiol is effective for managing epileptic seizures, curing psychiatric illness, and reducing inflammation.
- Legalization of Cannabis
The use and acceptance of medicinal cannabis continue to evolve, as the growing number of states are permitting the use of specific medical indications. Many countries have legalized marijuana for either medicinal or recreational purposes while some other countries with restricted use. In recent years, a growing number of states in the U.S. have legalized the drug for medical or recreational purposes. With the widespread legalization of cannabis, many companies are also becoming proactive and are taking initiatives for the complete legalization of cannabis.
The legalization of marijuana in different parts of the world can be seen as an effort to increase the additional revenue, this way there will be a boost in the revenue without raising taxes. The legalization of cannabis will allow more consumption of it for medicinal or recreational purposes. Moreover, it will also boost the cannabis business, thus creating more demand for cannabis. Hence, the legalization of cannabis is expected to drive market growth.
Opportunities
- Novel product development with increasing R&D activities
Medicinal cannabis comes in many different forms including capsules, chewable gum, creams, crystals, flower, lozenges, oil, and oro-mucosal sprays. High growth in the demand for cannabis with legalization has increased the need to come up with better product strains and delivery systems. This has led many companies to conduct R&D activities to check the genetic improvement strategies for cannabis. The FDA's Cannabis Product Committee (CPC) develops and implements cross-Agency strategies and policies for the regulation of cannabis products. The novel products that are developed and on the rise are hemp protein powders, energy bars, hemp milk, hemp flour, and hemp tea, which are expected to create opportunities for market growth.
- Increased adoption of cannabis for recreational purpose
Legalizing recreational marijuana results in helpful regulation of a safe drug, without increasing potential negative consequences. The legalization of marijuana has various societal benefits as the rise in the economy without increasing taxes, creating thousands of job opportunities, stopping the racial differences in marijuana enforcement, and freeing up scarce police resources. Legal recreational marijuana can end the costly enforcement of marijuana laws and debilitate the illegal marijuana market.
Due to these benefits, marijuana has been legalized and is being increasingly adopted by people of different age groups. This creates a demand for good-quality marijuana for fun and relaxation. Hence, the increasing adoption of cannabis for recreational purposes is expected to create opportunities for manufacturers in the market.
Restraint/Challenge
- High-cost purchasing and rush for premium quality
Medical cannabis devices can be expensive to manufacture and purchase, and the procedure cost can also be high due to the specialized equipment and training required. This can limit the accessibility of medical cannabis treatments for patients and healthcare facilities, particularly in lower-income regions. Additionally, the high cost of medical cannabis devices and procedures may deter some patients from choosing these treatments, especially if they have to pay out of pocket. Insurance coverage for medical cannabis treatments can also be limited, limiting their adoption.
As a result, the high cost of medical cannabis devices and procedures can be a significant barrier to market growth, especially in regions where cost is a major factor. However, as technology advances, the cost of these devices and procedures may decrease, making them more accessible to patients and healthcare facilities.
The increased intricacy of medical cannabis devices and the high cost of medical cannabis treatment are expected to restrain the market growth.
Recent Development
- In May 2018, as per the Cannabis Act of the Government of Canada, the cannabis act will create a strict legal framework for controlling the production, distribution, sale, and possession of cannabis across Canada which is meant to keep cannabis out of the hands of youth and profits out of pockets of organized crime by fostering a robust legal and regulated industry.
Asia-Pacific Medical Cannabis Market Scope
The Asia-Pacific medical cannabis market is segmented into nine notable segments based on product, source, species, derivatives, application, route of administration, treatment type, end user, and distribution channel. The growth amongst these segments will help you analyze market growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Oil
- Dried Medical Cannabis
- Medical Cannabis Capsules
- Vape Pen
- Whole Flower
- Creams & Moisturizer
- Ground Flower
- Patch
- Masks & Serum
- Cleanser
- Others
On the basis of product, the market is segmented into oil, medical cannabis capsules, patch, whole flower, ground flower, vape pen, dried medical cannabis, creams & moisturizer, masks & serum, cleanser, and others.
Source
- Synthetic
- Natural
On the basis of source, the market is segmented into synthetic and natural.
Species
- Cannabis Indica
- Sativa
- Hybrid
On the basis of species, the market is segmented into cannabis indica, sativa, and hybrid.
Derivatives
- Cannabidiol (CBD)
- Tetrahydrocannabinol (THC)/ Delta-8-Tetrahydrocannabinol
- Cannabigerol (CBG)
- Cannabichromene (CBC)
- Cannabinol (CBN)
- Cannabicyclol (CBL)
- Others
On the basis of derivatives, the market is segmented into Cannabidiol (CBD), tetrahydrocannabinol (THC)/delta-8-tetrahydrocannabinol, Cannabinol (CBN), Cannabicyclol (CBL), Cannabichromene (CBC), Cannabigerol (CBG), and others.
Application
- Pain Management
- Anxiety
- Muscle Spasm
- Nausea
- Appetite Loss
- Eating Disorders
- Inflammatory Bowel Diseases
- Cancer
- Arthritis
- Wasting Syndrome (Cachexia)
- Alzheimer’s Disease
- Epilepsy
- Depression and Sleep Disorder
- Multiple Sclerosis
- Autism
- Mental Health Conditions
- Elevate Mood
- Others
On the basis of application, the market is segmented into Alzheimer’s disease, appetite loss, cancer, inflammatory bowel diseases, eating disorders, epilepsy, autism, mental health conditions, multiple sclerosis, pain management, nausea, muscle spasms, wasting syndrome (cachexia), elevate mood, multiple sclerosis, depression and sleep disorders, anxiety, and others.
Route of Administration
- Oral Solutions and Capsules
- Smoking
- Vaporizers
- Topicals
- Others
On the basis of route of administration, the market is segmented into oral solutions and capsules, smoking, vaporizers, topicals, and others.
Treatment Type
- Analgesic
- Psychedelic
- Antiviral
- Aphrodisiac
- Expectorant
- Others
On the basis of treatment type, the market is segmented into expectorant, antiviral, analgesic, aphrodisiac, psychedelic, and others.
End User
- Homecare Setting
- Hospital
- Rehab Centers
- Pharmaceutical Industry
- Research and Development Centers
- Others
On the basis of end user, the market is segmented into pharmaceutical industry, research and development centers, homecare settings, hospital, rehab centers, and others.
Distribution Channel
- B2B
- B2C
On the basis of distribution channel, the market is segmented into B2B and B2C.
Asia-Pacific Medical Cannabis Market Regional Analysis/Insights
The Asia-Pacific medical cannabis market is segmented into nine notable segments based on product, source, species, derivatives, application, route of administration, treatment type, end user, and distribution channel.
The countries covered in this market report are Australia, Thailand, South Korea, Japan, China, New Zealand, Singapore, India, Taiwan, Malaysia, Philippines, and Rest of Asia-Pacific.
Australia is expected to dominate the Asia-Pacific medical cannabis market due to the presence of key manufacturers and advanced technological processes.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data
Competitive Landscape and Asia-Pacific Medical Cannabis Market Share Analysis
The Asia-Pacific medical cannabis market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, regional presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, brand analysis, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the companies’ focus related to the market.
Some of the major market players operating in this market are MediPharm Labs Inc., Tilray, Aurora Cannabis, JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc), HEXO Corp. (Zenabis Asia-Pacific Ltd), Cresco Labs, Peace Naturals Project Inc., CANOPY GROWTH CORPORATION, Medical Marijuana, Inc., Seed Cellar, EcoGen Biosciences, CANNABIS SEEDS USA, Seeds For Me, HUMBOLDT SEED COMPANY, Extractas, World Class Cannabis Seeds (Crop King Seeds), BARNEY'S FARM, FOLIUM BIOSCIENCES, PharmaHemp, Elixinol Asia-Pacific Limited, ENDOCA, Harmony, MARY’S nutritionals, LLC, Pure Ratios, Greenwich Biosciences, Inc., Upstate Elevator Supply Co., Apothecanna, BOL Pharma, and IDT Australia among others.
SKU-
目录
1 引言
1.1 研究目標
1.2 市場定義
1.3 亞太醫用大麻市場概況
1.4 限制
1.5 覆蓋市場
2 市場區隔
2.1 覆蓋市場
2.2 地理範圍
研究需時 2.3 年
2.4 貨幣和定價
2.5 DBMR三腳架資料驗證模型
2.6 多變量建模
2.7 產品生命線曲線
2.8 與關鍵意見領袖的初步訪談
2.9 DBMR 市場地位網格
2.1 市場應用覆蓋網格
2.11 供應商份額分析
2.12 第二手資料
2.13 假設
3 執行摘要
4 項優質見解
4.1 佩爾斯特分析
4.2 波特五力模型
5 產業洞察
5.1 產業洞察專利分析
5.2 成熟市場的藥物治療率
5.3 人口趨勢：對所有發病率的影響
5.4 患者流程圖
5.5 關鍵定價策略
5.6 關鍵患者入組策略
6 監管情景
6.1 澳大利亞
6.2 泰國
6.3 日本
6.4 中國
6.5 紐西蘭
6.6 新加坡
6.7 印度
6.8 馬來西亞
6.9 菲律賓
7 市場概覽
7.1 驅動程式
7.1.1 大麻在醫藥中的使用增加
7.1.2 大麻合法化
7.1.3 主要參與者所採取的策略性舉措
7.1.4 需要使用大麻的疾病盛行率上升
7.2 限制
7.2.1 大麻使用的複雜監管結構
7.2.2 長期使用所引起的不良反應
7.2.3 高成本採購，追求高品質
7.3 機遇
7.3.1 新產品開發，研發活動不斷增加
7.3.2 娛樂用途大麻的使用增加
7.3.3 老年人口不斷成長
7.4 挑戰
7.4.1 大麻黑市的興起
7.4.2 與使用大麻有關的副作用
7.4.3 技能人才短缺
8 亞太醫用大麻市場（按產品）
8.1 概述
8.2 石油
8.2.1 石油（按類型）
8.2.1.1 CBD油濃縮物
8.2.1.2 CBD電子煙油
8.2.1.3 CBD酊劑
8.2.2 石油，依來源
8.2.2.1 大麻基
8.2.2.2 大麻類
8.2.3 石油（依種類）
8.2.3.1 苜蓿
8.2.3.2 混合
8.2.3.3 印度大麻
8.2.4 石油，依產品類型
8.2.4.1 品牌
8.2.4.1.1 企鵝CBD油
8.2.4.1.2 FAB CBD油
8.2.4.1.3 GREEN ROADS 廣譜 CBD 油
8.2.4.1.4 其他
8.2.4.2 通用
8.3 乾燥醫用大麻
8.3.1 印度大麻
8.3.2 苜蓿
8.3.3 混合
8.4 醫用大麻膠囊
8.4.1 醫用大麻膠囊（依類型）
8.4.1.1 油基大麻膠囊
8.4.1.2 粉狀大麻膠囊
8.4.1.3 液體大麻膠囊
8.4.1.4 其他
8.4.2 醫用大麻膠囊（依濃縮物）
8.4.2.1 高 CBD 膠囊數位版
8.4.2.2 高THC膠囊
8.4.2.3 THC/CBD平衡膠囊
8.4.2.4 CBD分離膠囊
8.4.3 醫用大麻膠囊（依種類）
8.4.3.1 苜蓿
8.4.3.2 印度大麻
8.4.4 醫用大麻膠囊（依產品類型）
8.4.4.1 品牌
8.4.4.1.1 快樂營養
8.4.4.1.2 MEDTERRA 分離 CBD 凝膠膠囊
8.4.4.1.3 拉撒路自然
8.4.4.1.4 其他
8.4.4.2 通用
8.5 電子煙
8.5.1 電子煙，依種類
8.5.1.1 苜蓿
8.5.1.2 混合
8.5.1.3 印度大麻
8.5.2 電子煙，依產品類型
8.5.2.1 品牌
8.5.2.1.1 康迪彭斯‧魯比
8.5.2.1.2 SOL E-NECTAR 收集器
8.5.2.1.3 PAX ERA PRO-OIL 電子煙筆
8.5.2.2 通用
8.6 整朵花
8.6.1 整朵花，種類
8.6.1.1 苜蓿
8.6.1.2 混合
8.6.1.3 印度大麻
8.6.2 整花，產品類型
8.6.2.1 品牌
8.6.2.1.1 紫苑農場
8.6.2.1.2 RA 花
8.6.2.1.3 壞蘋果
8.6.2.2 通用
8.7 乳霜和保濕霜
8.7.1 乳霜和保濕霜（依種類）
8.7.1.1 苜蓿
8.7.1.2 混合
8.7.1.3 印度大麻
8.7.2 乳霜和保濕霜，依產品類型
8.7.2.1 品牌
8.7.2.1.1 CBDFX 肌肉和關節
8.7.2.1.2 ASPEN GREEN 肌肉舒緩清涼霜
8.7.2.1.3 MEDTERRA 止痛膏
8.7.2.2 通用
8.8 地花
8.8.1 地上花卉（依種類）
8.8.1.1 苜蓿
8.8.1.2 混合
8.8.1.3 印度大麻
8.8.2 地花，依產品類型
8.8.2.1 品牌
8.8.2.1.1 紫苑農場
8.8.2.1.2 RA 花
8.8.2.1.3 壞蘋果
8.8.2.2 通用
8.9補丁
8.9.1 補丁（按類型）
8.9.1.1 水庫
8.9.1.2 黏合劑中的藥物層
8.9.1.3 其他
8.9.2 斑塊，依物種
8.9.2.1 苜蓿
8.9.2.2 印度大麻
8.9.2.3 混合
8.9.3 補丁（依產品類型）
8.9.3.1 品牌
8.9.3.1.1 大麻炸彈
8.9.3.1.2 普雷卡納
8.9.3.1.3 純比例
8.9.3.1.4 水庫
8.9.3.2 通用
8.1 面膜和精華液
8.10.1 面膜和精華液（依種類）
8.10.1.1 苜蓿
8.10.1.2 印度大麻
8.10.1.3 混合
8.10.2 面膜和精華液，依產品類型
8.10.2.1 品牌
8.10.2.1.1 碰撞與平滑CBD
8.10.2.1.2 臉部精華
8.10.2.1.3 其他
8.10.2.2 通用
8.11 潔面乳
8.11.1 清潔劑（依種類）
8.11.1.1 苜蓿
8.11.1.2 混合
8.11.1.3 印度大麻
8.11.2 清潔劑（依產品類型）
8.11.2.1 品牌
8.11.2.1.1 科顏氏
8.11.2.1.2 CBD 101
8.11.2.1.3 其他
8.11.2.2 通用
8.12 其他
9 亞太醫用大麻市場（依品種劃分）
9.1 概述
9.2 苜蓿
9.3 混合
9.4 印度大麻
10 亞太醫用大麻市場（依衍生性商品劃分）
10.1 概述
10.2 大麻二酚（CBD）
10.3 四氫大麻酚（THC）/δ-8-四氫大麻酚
10.4 大麻萜酚（CBG）
10.5 大麻色素（CBC）
10.6 大麻酚（CBN）
10.7 大麻環醇（CBL）
10.8 其他
11 亞太醫用大麻市場（按應用）
11.1 概述
11.2 疼痛管理
11.2.1 疼痛管理（按類型）
11.2.1.1 慢性疼痛
11.2.1.2 非癌症慢性疼痛
11.2.1.3 神經性疼痛
11.2.2 疼痛管理（副產品）
11.2.2.1 石油
11.2.2.2 乾燥醫用大麻
11.2.2.3 醫用大麻膠囊
11.2.2.4 補丁
11.2.2.5 地花
11.2.2.6 乳霜和保濕霜
11.2.2.7 電子煙
11.2.2.8 整朵花
11.2.2.9 面膜和精華液
11.2.2.10 清潔劑
11.2.2.11 其他
11.3 焦慮
11.3.1 石油
11.3.2 乾燥醫用大麻
11.3.3 醫用大麻膠囊
11.3.4 補丁
11.3.5 地花
11.3.6 乳霜和保濕霜
11.3.7 電子煙
11.3.8 整朵花
11.3.9 面膜和精華液
11.3.10 清潔劑
11.3.11 其他
11.4 肌肉痙攣
11.4.1 石油
11.4.2 乾燥醫用大麻
11.4.3 醫用大麻膠囊
11.4.4 補丁
11.4.5 地花
11.4.6 乳霜和保濕霜
11.4.7 電子煙
11.4.8 整朵花
11.4.9 面膜和精華液
11.4.10 清潔劑
11.4.11 其他
11.5 噁心
11.5.1 石油
11.5.2 乾燥醫用大麻
11.5.3 醫用大麻膠囊
11.5.4 補丁
11.5.5 地花
11.5.6 面霜和保濕霜
11.5.7 電子煙
11.5.8 整朵花
11.5.9 面膜和精華液
11.5.10 清潔劑
11.5.11 其他
11.6 食慾不振
11.6.1 石油
11.6.2 乾燥醫用大麻
11.6.3 醫用大麻膠囊
11.6.4 補丁
11.6.5 地花
11.6.6 乳霜和保濕霜
11.6.7 電子煙
11.6.8 整朵花
11.6.9 面膜和精華液
11.6.10 清潔劑
11.6.11 其他
11.7 飲食失調
11.7.1 石油
11.7.2 乾燥醫用大麻
11.7.3 醫用大麻膠囊
11.7.4 補丁
11.7.5 地花
11.7.6 乳霜和保濕霜
11.7.7 電子煙
11.7.8 整朵花
11.7.9 面膜和精華液
11.7.10 清潔劑
11.7.11 其他
11.8 發炎性腸道疾病
11.8.1 石油
11.8.2 乾燥醫用大麻
11.8.3 醫用大麻膠囊
11.8.4 補丁
11.8.5 地花
11.8.6 乳霜和保濕霜
11.8.7 電子煙
11.8.8 整朵花
11.8.9 面膜和精華液
11.8.10 清潔劑
11.8.11 其他
11.9 癌症
11.9.1 石油
11.9.2 乾燥醫用大麻
11.9.3 醫用大麻膠囊
11.9.4 補丁
11.9.5 地花
11.9.6 乳霜和保濕霜
11.9.7 電子煙
11.9.8 整朵花
11.9.9 面膜和精華液
11.9.10 清潔劑
11.9.11 其他
11.1 關節炎
11.10.1 石油
11.10.2 乾燥醫用大麻
11.10.3 醫用大麻膠囊
11.10.4補丁
11.10.5 地花
11.10.6 乳霜和保濕霜
11.10.7 電子煙
11.10.8 整朵花
11.10.9 面膜和精華液
11.10.10 潔面乳
11.10.11 其他
11.11 洗滌症候群（惡病質）
11.11.1 石油
11.11.2 乾燥醫用大麻
11.11.3 醫用大麻膠囊
11.11.4補丁
11.11.5 地花
11.11.6 乳霜和保濕霜
11.11.7 電子煙
11.11.8 整朵花
11.11.9 面膜和精華液
11.11.10 潔面乳
11.11.11 其他
11.12 阿茲海默症
11.12.1 石油
11.12.2 乾燥醫用大麻
11.12.3 醫用大麻膠囊
11.12.4補丁
11.12.5 地花
11.12.6 乳霜和保濕霜
11.12.7 電子煙
11.12.8 整朵花
11.12.9 面膜和精華液
11.12.10 潔面乳
11.12.11 其他
11.13 癲癇
11.13.1 石油
11.13.2 乾燥醫用大麻
11.13.3 醫用大麻膠囊
11.13.4補丁
11.13.5 地花
11.13.6 乳霜和保濕霜
11.13.7 電子煙
11.13.8 整朵花
11.13.9 面膜和精華液
11.13.10 潔面乳
11.13.11 其他
11.14 憂鬱症和睡眠障礙
11.14.1 石油
11.14.2 乾燥醫用大麻
11.14.3 醫用大麻膠囊
11.14.4補丁
11.14.5 地花
11.14.6 乳霜和保濕霜
11.14.7 電子煙
11.14.8 整朵花
11.14.9 面膜和精華液
11.14.10 潔面乳
11.14.11 其他
11.15 多發性硬化症
11.15.1 石油
11.15.2 乾燥醫用大麻
11.15.3 醫用大麻膠囊
11.15.4補丁
11.15.5 地花
11.15.6 乳霜和保濕霜
11.15.7 電子煙
11.15.8 整朵花
11.15.9 面膜和精華液
11.15.10 潔面乳
11.15.11 其他
11.16 自閉症
11.16.1 石油
11.16.2 乾燥醫用大麻
11.16.3 醫用大麻膠囊
11.16.4補丁
11.16.5 地花
11.16.6 乳霜和保濕霜
11.16.7 電子煙
11.16.8 整朵花
11.16.9 面膜和精華液
11.16.10 潔面乳
11.16.11 其他
11.17 精神健康狀況
11.17.1 精神健康狀況（按類型）
11.17.1.1 創傷後壓力症候群（PTSD）
11.17.1.2 精神分裂症
11.17.1.3 其他
11.17.2 精神健康狀況（按類型）
11.17.2.1 石油
11.17.2.2 乾燥醫用大麻
11.17.2.3 醫用大麻膠囊
11.17.2.4 補丁
11.17.2.5 地花
11.17.2.6 乳霜和保濕霜
11.17.2.7 電子煙
11.17.2.8 整朵花
11.17.2.9 面膜和精華液
11.17.2.10 清潔劑
11.17.2.11 其他
11.18 提升心情
11.18.1 石油
11.18.2 乾燥醫用大麻
11.18.3 醫用大麻膠囊
11.18.4補丁
11.18.5 地花
11.18.6 乳霜和保濕霜
11.18.7 電子煙
11.18.8 整朵花
11.18.9 面膜和精華液
11.18.10 潔面乳
11.18.11 其他
11.19 其他
12 亞太醫用大麻市場（依給藥途徑）
12.1 概述
12.2 口服溶液和膠囊
12.3 吸煙
12.4 外用藥
12.5 汽化器
12.6 其他
13 亞太醫用大麻市場（依治療類型劃分）
13.1 概述
13.2 鎮痛藥
13.3 迷幻
13.4 抗病毒藥物
13.5 春藥
13.6 祛痰藥
13.7 其他
14 亞太醫用大麻市場（按最終用戶劃分）
14.1 概述
14.2 家庭照護環境
14.3 醫院
14.4 復健中心
14.5 製藥業
14.6 研發中心
14.7 其他
15 亞太醫用大麻市場（依分銷管道劃分）
15.1 概述
15.2 B2C
15.2.1 藥局
15.2.2 傳統商店
15.2.3 網上商店
15.2.4 其他
15.3 B2B
16 亞太醫用大麻市場（按地區）
16.1 亞太地區
16.1.1 澳大利亞
16.1.2 泰國
16.1.3 韓國
16.1.4 日本
16.1.5 中國
16.1.6 紐西蘭
16.1.7 新加坡
16.1.8 印度
16.1.9 台灣
16.1.10 馬來西亞
16.1.11 菲律賓
16.1.12 亞太其他地區
17 亞太醫用大麻市場：公司格局
17.1 公司份額分析：亞太地區
18 公司簡介
18.1 MEDIPHARM 實驗室公司
18.1.1 公司概況
18.1.2 收入分析
18.1.3 公司股份分析
18.1.4 產品組合
18.1.5 近期發展
18.2 蒂爾雷
18.2.1 公司概況
18.2.2 公司股份分析
18.2.3 產品組合
18.2.4 近期發展
18.3 極光大麻
18.3.1 公司概況
18.3.2 收入分析
18.3.3 公司股份分析
18.3.4 產品組合
18.3.5 近期發展
18.4 JAZZ PHARMACEUTICALS INC.（GW PHARMACEUTICALS PLC）
18.4.1 公司概況
18.4.2 收入分析
18.4.3 公司股份分析
18.4.4 產品組合
18.4.5 近期發展
18.5 HEXO 公司（ZENABIS 亞太有限公司）
18.5.1 公司概況
18.5.2 收入分析
18.5.3 公司股份分析
18.5.4 產品組合
18.5.5 近期發展
18.6 藥劑師
18.6.1 公司概況
18.6.2 產品組合
18.6.3 最近的發展
18.7 博爾製藥
18.7.1 公司概況
18.7.2 產品組合
18.7.3 近期發展
18.8 巴尼農場
18.8.1 公司概況
18.8.2 產品組合
18.8.3 近期發展
18.9 冠層生長公司
18.9.1 公司概況
18.9.2 收入分析
18.9.3 產品組合
18.9.4 近期發展
18.1 美國大麻種子
18.10.1 公司概況
18.10.2 產品組合
18.10.3 最近的發展
18.11 CRESCO實驗室
18.11.1 公司概況
18.11.2 產品組合
18.11.3 近期發展
18.12 生態生物科學
18.12.1 公司概況
18.12.2 產品組合
18.12.3 近期發展
18.13 ELIXINOL亞太有限公司
18.13.1 公司概況
18.13.2 收入分析
18.13.3 產品組合
18.13.4 近期發展
18.14 內視鏡
18.14.1 公司概況
18.14.2 產品組合
18.14.3 最近的發展
18.15 萃取物
18.15.1 公司概況
18.15.2 產品組合
18.15.3 最近的發展
18.16 FOLIUM BIOSCIENCES
18.16.1 公司概況
18.16.2 產品組合
18.16.3 近期發展
18.17 格林威治生物科學公司
18.17.1 公司概況
18.17.2 產品組合
18.17.3 近期發展
18.18 和諧
18.18.1 公司概況
18.18.2 產品組合
18.18.3 近期發展
18.19 洪堡種子公司
18.19.1 公司概況
18.19.2 產品組合
18.19.3 最近的發展
18.2 IDT 澳大利亞
18.20.1 公司概況
18.20.2 收入分析
18.20.3 產品組合
18.20.4 近期發展
18.21 瑪麗營養有限公司
18.21.1 公司概況
18.21.2 產品組合
18.21.3 最近的發展
18.22 醫用大麻公司
18.22.1 公司概況
18.22.2 收入分析
18.22.3 產品組合
18.22.4 近期發展
18.23 和平自然專案公司
18.23.1 公司概況
18.23.2 產品組合
18.23.3 最近的發展
18.24 藥用大麻
18.24.1 公司概況
18.24.2 產品組合
18.24.3 最近的發展
18.25 純比例
18.25.1 公司概況
18.25.2 產品組合
18.25.3 最近的發展
18.26 種子給我
18.26.1 公司概況
18.26.2 產品組合
18.26.3 最近的發展
18.27 種子窖
18.27.1 公司概況
18.27.2 產品組合
18.27.3 最近的發展
18.28 上州電梯供應公司
18.28.1 公司概況
18.28.2 產品組合
18.28.3 最近的發展
18.29 世界級大麻種子（CROP KING SEEDS）
18.29.1 公司概況
18.29.2 產品組合
18.29.3 最近的發展
19 問卷
20份相關報告
表格列表
TABLE 1 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 2 ASIA PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 ASIA PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 4 ASIA PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 5 ASIA PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 6 ASIA PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 7 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 ASIA PACIFIC DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 ASIA PACIFIC DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 10 ASIA PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 ASIA PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 12 ASIA PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 13 ASIA PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 14 ASIA PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 15 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 16 ASIA PACIFIC VAPE PEN IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 ASIA PACIFIC VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 18 ASIA PACIFIC VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 19 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 20 ASIA PACIFIC WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 ASIA PACIFIC WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 22 ASIA PACIFIC WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 23 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 24 ASIA PACIFIC CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 ASIA PACIFIC CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 26 ASIA PACIFIC CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 27 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 28 ASIA PACIFIC GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 ASIA PACIFIC GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 30 ASIA PACIFIC GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 31 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 32 ASIA PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 ASIA PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 34 ASIA PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 35 ASIA PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 36 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 37 ASIA PACIFIC MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 ASIA PACIFIC MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 39 ASIA PACIFIC MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 40 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 41 ASIA PACIFIC CLEANSER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 ASIA PACIFIC CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 43 ASIA PACIFIC CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 44 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 45 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 46 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 47 ASIA PACIFIC SATIVA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 48 ASIA PACIFIC HYBRID IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 49 ASIA PACIFIC CANNABIS INDICA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 50 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 51 ASIA PACIFIC CANNABIDIOL (CBD) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 52 ASIA PACIFIC TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 53 ASIA PACIFIC CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 54 ASIA PACIFIC CANNABICHROMENE (CBC) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 55 ASIA PACIFIC CANNABINOL (CBN) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 56 ASIA PACIFIC CANNABICYCLOL (CBL) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 57 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 58 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 59 ASIA PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 60 ASIA PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 61 ASIA PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 62 ASIA PACIFIC ANXIETY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 63 ASIA PACIFIC ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 64 ASIA PACIFIC MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 65 ASIA PACIFIC MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 66 ASIA PACIFIC NAUSEA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 67 ASIA PACIFIC NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 68 ASIA PACIFIC APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 69 ASIA PACIFIC APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 70 ASIA PACIFIC EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 71 ASIA PACIFIC EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 72 ASIA PACIFIC INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 73 ASIA PACIFIC INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 74 ASIA PACIFIC CANCER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 75 ASIA PACIFIC CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 76 ASIA PACIFIC ARTHRITIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 77 ASIA PACIFIC ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 78 ASIA PACIFIC WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 79 ASIA PACIFIC WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 80 ASIA PACIFIC ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 81 ASIA PACIFIC ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 82 ASIA PACIFIC EPILEPSY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 83 ASIA PACIFIC EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 84 ASIA PACIFIC DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 85 ASIA PACIFIC DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 86 ASIA PACIFIC MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 87 ASIA PACIFIC MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 88 ASIA PACIFIC AUTISM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 89 ASIA PACIFIC AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 90 ASIA PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 91 ASIA PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 92 ASIA PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 93 ASIA PACIFIC ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 94 ASIA PACIFIC ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 95 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 96 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 97 ASIA PACIFIC ORAL SOLUTIONS AND CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 98 ASIA PACIFIC SMOKING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 99 ASIA PACIFIC TOPICALS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 100 ASIA PACIFIC VAPORIZERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 101 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 102 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 103 ASIA PACIFIC ANALGESIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 104 ASIA PACIFIC PSYCHEDELIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 105 ASIA PACIFIC ANTIVIRAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 106 ASIA PACIFIC APHRODISIAC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 107 ASIA PACIFIC EXPECTORANT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 108 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 109 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 110 ASIA PACIFIC HOMECARE SETTING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 111 ASIA PACIFIC HOSPITAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 112 ASIA PACIFIC REHAB CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 113 ASIA PACIFIC PHARMACEUTICAL INDUSTRY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 114 ASIA PACIFIC RESEARCH AND DEVELOPMENT CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 115 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 116 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 117 ASIA PACIFIC B2C IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 118 ASIA PACIFIC B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 119 ASIA PACIFIC B2B IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 120 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 121 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 122 ASIA-PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 123 ASIA-PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 124 ASIA-PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 125 ASIA-PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 126 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 127 ASIA-PACIFIC DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 128 ASIA-PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 129 ASIA-PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 130 ASIA-PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 131 ASIA-PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 132 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 133 ASIA-PACIFIC VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 134 ASIA-PACIFIC VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 135 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 ASIA-PACIFIC WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 137 ASIA-PACIFIC WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 138 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 ASIA-PACIFIC CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 140 ASIA-PACIFIC CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 141 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 142 ASIA-PACIFIC GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 143 ASIA-PACIFIC GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 144 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 145 ASIA-PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 146 ASIA-PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 147 ASIA-PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 148 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 149 ASIA-PACIFIC MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 150 ASIA-PACIFIC MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 151 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 152 ASIA-PACIFIC CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 153 ASIA-PACIFIC CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 154 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 155 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 156 ASIA-PACIFIC SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 157 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 158 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 159 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 160 ASIA-PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 161 ASIA-PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 162 ASIA-PACIFIC ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 163 ASIA-PACIFIC MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 164 ASIA-PACIFIC NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 165 ASIA-PACIFIC APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 166 ASIA-PACIFIC EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 167 ASIA-PACIFIC INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 168 ASIA-PACIFIC CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 169 ASIA-PACIFIC ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 170 ASIA-PACIFIC WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 171 ASIA-PACIFIC ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 172 ASIA-PACIFIC EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 173 ASIA-PACIFIC DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 174 ASIA-PACIFIC MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 175 ASIA-PACIFIC AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 176 ASIA-PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 177 ASIA-PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 178 ASIA-PACIFIC ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 179 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 180 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 181 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 182 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 183 ASIA-PACIFIC B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 184 AUSTRALIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 185 AUSTRALIA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 186 AUSTRALIA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 187 AUSTRALIA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 188 AUSTRALIA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 189 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 190 AUSTRALIA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 191 AUSTRALIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 192 AUSTRALIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 193 AUSTRALIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 194 AUSTRALIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 195 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 196 AUSTRALIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 197 AUSTRALIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 198 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 199 AUSTRALIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 200 AUSTRALIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 201 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 202 AUSTRALIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 203 AUSTRALIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 204 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 205 AUSTRALIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 206 AUSTRALIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 207 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 208 AUSTRALIA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 209 AUSTRALIA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 210 AUSTRALIA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 211 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 212 AUSTRALIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 213 AUSTRALIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 214 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 215 AUSTRALIA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 216 AUSTRALIA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 217 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 AUSTRALIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 219 AUSTRALIA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 220 AUSTRALIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 221 AUSTRALIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 222 AUSTRALIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 223 AUSTRALIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 224 AUSTRALIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 225 AUSTRALIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 226 AUSTRALIA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 227 AUSTRALIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 228 AUSTRALIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 229 AUSTRALIA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 230 AUSTRALIA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 231 AUSTRALIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 232 AUSTRALIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 233 AUSTRALIA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 234 AUSTRALIA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 235 AUSTRALIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 236 AUSTRALIA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 237 AUSTRALIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 238 AUSTRALIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 239 AUSTRALIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 240 AUSTRALIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 241 AUSTRALIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 242 AUSTRALIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 243 AUSTRALIA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 244 AUSTRALIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 245 AUSTRALIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 246 AUSTRALIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 247 THAILAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 248 THAILAND OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 249 THAILAND OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 250 THAILAND OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 251 THAILAND OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 252 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 253 THAILAND DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 254 THAILAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 255 THAILAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 256 THAILAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 257 THAILAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 258 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 259 THAILAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 260 THAILAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 261 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 262 THAILAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 263 THAILAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 264 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 265 THAILAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 266 THAILAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 267 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 268 THAILAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 269 THAILAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 270 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 271 THAILAND PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 272 THAILAND PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 273 THAILAND PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 274 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 275 THAILAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 276 THAILAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 277 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 278 THAILAND CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 279 THAILAND CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 280 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 281 THAILAND MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 282 THAILAND SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 283 THAILAND MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 284 THAILAND MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 285 THAILAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 286 THAILAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 287 THAILAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 288 THAILAND ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 289 THAILAND MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 290 THAILAND NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 291 THAILAND APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 292 THAILAND EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 293 THAILAND INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 294 THAILAND CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 295 THAILAND ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 296 THAILAND WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 297 THAILAND ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 298 THAILAND EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 299 THAILAND DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 300 THAILAND MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 301 THAILAND AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 302 THAILAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 303 THAILAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 304 THAILAND ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 305 THAILAND MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 306 THAILAND MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 307 THAILAND MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 308 THAILAND MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 309 THAILAND B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 310 SOUTH KOREA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 311 SOUTH KOREA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 312 SOUTH KOREA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 313 SOUTH KOREA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 314 SOUTH KOREA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 315 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 316 SOUTH KOREA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 317 SOUTH KOREA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 318 SOUTH KOREA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 319 SOUTH KOREA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 320 SOUTH KOREA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 321 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 322 SOUTH KOREA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 323 SOUTH KOREA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 324 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 325 SOUTH KOREA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 326 SOUTH KOREA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 327 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 328 SOUTH KOREA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 329 SOUTH KOREA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 330 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 331 SOUTH KOREA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 332 SOUTH KOREA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 333 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 334 SOUTH KOREA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 335 SOUTH KOREA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 336 SOUTH KOREA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 337 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 338 SOUTH KOREA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 339 SOUTH KOREA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 340 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 341 SOUTH KOREA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 342 SOUTH KOREA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 343 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 344 SOUTH KOREA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 345 SOUTH KOREA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 346 SOUTH KOREA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 347 SOUTH KOREA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 348 SOUTH KOREA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 349 SOUTH KOREA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 350 SOUTH KOREA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 351 SOUTH KOREA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 352 SOUTH KOREA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 353 SOUTH KOREA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 354 SOUTH KOREA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 355 SOUTH KOREA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 356 SOUTH KOREA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 357 SOUTH KOREA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 358 SOUTH KOREA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 359 SOUTH KOREA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 360 SOUTH KOREA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 361 SOUTH KOREA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 362 SOUTH KOREA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 363 SOUTH KOREA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 364 SOUTH KOREA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 365 SOUTH KOREA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 366 SOUTH KOREA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 367 SOUTH KOREA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 368 SOUTH KOREA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 369 SOUTH KOREA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 370 SOUTH KOREA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 371 SOUTH KOREA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 372 SOUTH KOREA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 373 JAPAN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 374 JAPAN OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 375 JAPAN OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 376 JAPAN OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 377 JAPAN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 378 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 379 JAPAN DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 380 JAPAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 381 JAPAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 382 JAPAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 383 JAPAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 384 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 385 JAPAN VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 386 JAPAN VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 387 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 388 JAPAN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 389 JAPAN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 390 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 391 JAPAN CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 392 JAPAN CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 393 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 394 JAPAN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 395 JAPAN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 396 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 397 JAPAN PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 398 JAPAN PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 399 JAPAN PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 400 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 401 JAPAN MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 402 JAPAN MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 403 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 404 JAPAN CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 405 JAPAN CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 406 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 407 JAPAN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 408 JAPAN SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 409 JAPAN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 410 JAPAN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 411 JAPAN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 412 JAPAN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 413 JAPAN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 414 JAPAN ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 415 JAPAN MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 416 JAPAN NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 417 JAPAN APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 418 JAPAN EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 419 JAPAN INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 420 JAPAN CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 421 JAPAN ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 422 JAPAN WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 423 JAPAN ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 424 JAPAN EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 425 JAPAN DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 426 JAPAN MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 427 JAPAN AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 428 JAPAN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 429 JAPAN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 430 JAPAN ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 431 JAPAN MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 432 JAPAN MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 433 JAPAN MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 434 JAPAN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 435 JAPAN B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 436 CHINA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 437 CHINA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 438 CHINA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 439 CHINA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 440 CHINA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 441 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 442 CHINA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 443 CHINA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 444 CHINA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 445 CHINA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 446 CHINA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 447 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 448 CHINA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 449 CHINA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 450 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 451 CHINA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 452 CHINA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 453 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 454 CHINA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 455 CHINA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 456 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 457 CHINA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 458 CHINA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 459 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 460 CHINA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 461 CHINA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 462 CHINA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 463 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 464 CHINA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 465 CHINA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 466 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 467 CHINA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 468 CHINA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 469 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 470 CHINA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 471 CHINA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 472 CHINA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 473 CHINA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 474 CHINA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 475 CHINA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 476 CHINA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 477 CHINA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 478 CHINA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 479 CHINA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 480 CHINA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 481 CHINA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 482 CHINA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 483 CHINA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 484 CHINA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 485 CHINA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 486 CHINA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 487 CHINA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 488 CHINA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 489 CHINA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 490 CHINA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 491 CHINA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 492 CHINA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 493 CHINA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 494 CHINA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 495 CHINA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 496 CHINA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 497 CHINA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 498 CHINA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 499 NEW ZEALAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 500 NEW ZEALAND OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 501 NEW ZEALAND OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 502 NEW ZEALAND OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 503 NEW ZEALAND OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 504 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 505 NEW ZEALAND DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 506 NEW ZEALAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 507 NEW ZEALAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 508 NEW ZEALAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 509 NEW ZEALAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 510 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 511 NEW ZEALAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 512 NEW ZEALAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 513 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 514 NEW ZEALAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 515 NEW ZEALAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 516 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 517 NEW ZEALAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 518 NEW ZEALAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 519 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 520 NEW ZEALAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 521 NEW ZEALAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 522 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 523 NEW ZEALAND PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 524 NEW ZEALAND PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 525 NEW ZEALAND PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 526 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 527 NEW ZEALAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 528 NEW ZEALAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 529 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 530 NEW ZEALAND CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 531 NEW ZEALAND CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 532 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 533 NEW ZEALAND MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 534 NEW ZEALAND SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 535 NEW ZEALAND MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 536 NEW ZEALAND MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 537 NEW ZEALAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 538 NEW ZEALAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 539 NEW ZEALAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 540 NEW ZEALAND ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 541 NEW ZEALAND MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 542 NEW ZEALAND NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 543 NEW ZEALAND APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
表544 紐西蘭醫用大麻市場中的飲食失調，依應用，2021-2030年（百萬美元）
表545 紐西蘭醫用大麻市場發炎性腸道疾病，依應用，2021-2030年（百萬美元）
表546 紐西蘭醫用大麻市場癌症應用情況，2021-2030（百萬美元）
表547 紐西蘭醫用大麻市場中的關節炎，按應用，2021-2030（百萬美元）
表548紐西蘭醫用大麻市場的消瘦症候群（惡病質），依應用，2021-2030年（百萬美元）
表549紐西蘭阿茲海默症醫用大麻市場，依應用，2021-2030年（百萬美元）
表550紐西蘭醫用大麻市場中的癲癇，按應用，2021-2030年（百萬美元）
表551 紐西蘭醫用大麻市場憂鬱症與睡眠障礙，依應用，2021-2030年（百萬美元）
表552 紐西蘭醫用大麻市場中的多發性硬化症，依應用，2021-2030年（百萬美元）
表553 紐西蘭自閉症醫用大麻市場，按應用，2021-2030年（百萬美元）
表 554 紐西蘭醫用大麻市場的精神健康狀況（按類型），2021-2030 年（百萬美元）
表555 紐西蘭醫用大麻市場的精神健康狀況，依產品，2021-2030年（百萬美元）
表556 紐西蘭醫用大麻市場提升情緒，依應用，2021-2030年（百萬美元）
表 557 紐西蘭醫用大麻市場，依管理途徑，2021-2030 年（百萬美元）
表 558 紐西蘭醫用大麻市場，依治療類型，2021-2030 年（百萬美元）
表559 紐西蘭醫用大麻市場，按最終用戶，2021-2030（百萬美元）
表 560 紐西蘭醫用大麻市場，依分銷管道，2021-2030 年（百萬美元）
表 561 紐西蘭醫用大麻市場 B2C，依分銷管道，2021-2030 年（百萬美元）
表562 新加坡醫用大麻市場，依產品，2021-2030（百萬美元）
表 563 新加坡醫用大麻市場石油（按類型），2021-2030 年（百萬美元）
表 564 新加坡醫用大麻市場石油，依來源劃分，2021-2030 年（百萬美元）
表 565 新加坡醫用大麻市場石油，依品種，2021-2030 年（百萬美元）
表 566 新加坡醫用大麻市場石油（依產品類型），2021-2030 年（百萬美元）
表567 新加坡醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表568 新加坡醫用大麻市場乾燥醫用大麻（依產品），2021-2030年（百萬美元）
表569 新加坡醫用大麻市場中的醫用大麻膠囊，按類型，2021-2030（百萬美元）
表570 新加坡醫用大麻市場中的醫用大麻膠囊，依濃縮物，2021-2030年（百萬美元）
表571 新加坡醫用大麻市場中的醫用大麻膠囊，依種類，2021-2030（百萬美元）
表572 新加坡醫用大麻市場中的醫用大麻膠囊，依產品類型，2021-2030年（百萬美元）
表573 新加坡醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表574 新加坡醫用大麻市場中的VAPE筆，依種類，2021-2030（百萬美元）
表575 新加坡醫用大麻市場中的VAPE筆，依產品類型，2021-2030（百萬美元）
表576 新加坡醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表577 新加坡醫用大麻全花市場（依品種劃分），2021-2030年（百萬美元）
表578 新加坡醫用大麻全花市場，依產品類型，2021-2030年（百萬美元）
表579 新加坡醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表580 新加坡醫用大麻市場中的乳霜和保濕霜，依種類，2021-2030年（百萬美元）
表581 新加坡醫用大麻市場中的乳霜和保濕霜，依產品類型，2021-2030年（百萬美元）
表582 新加坡醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表583 2021-2030年新加坡醫用大麻市場地花產量（依品種劃分）（百萬美元）
表584 新加坡醫用大麻市場地花，依產品類型，2021-2030年（百萬美元）
表585 新加坡醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表 586 新加坡醫用大麻市場貼片，按類型，2021-2030 年（百萬美元）
表 587 新加坡醫用大麻市場貼片，依種類，2021-2030 年（百萬美元）
表 588 新加坡醫用大麻貼片市場，依產品類型，2021-2030 年（百萬美元）
表589 新加坡醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表590 新加坡醫用大麻市場中的口罩和精華液，依種類，2021-2030年（百萬美元）
表591 新加坡醫用大麻市場中的口罩和精華液，依產品類型，2021-2030年（百萬美元）
表592 新加坡醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表593 新加坡醫用大麻清潔劑市場，依種類，2021-2030（百萬美元）
表594 新加坡醫用大麻清潔劑市場（依產品類型），2021-2030年（百萬美元）
表595 新加坡醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表 596 新加坡醫用大麻市場，依來源，2021-2030 年（百萬美元）
表597 新加坡醫用大麻合成市場，依來源，2021-2030年（百萬美元）
表598 新加坡醫用大麻市場，依種類，2021-2030年（百萬美元）
表599 新加坡醫用大麻市場（依衍生性商品劃分），2021-2030 年（百萬美元）
表 600 新加坡醫用大麻市場，按應用，2021-2030 年（百萬美元）
表601 新加坡醫用大麻市場疼痛管理（按類型），2021-2030年（百萬美元）
表602 新加坡醫用大麻市場疼痛管理（依產品），2021-2030年（百萬美元）
表 603 新加坡醫用大麻市場焦慮情況（按應用），2021-2030 年（百萬美元）
表 604 新加坡醫用大麻市場的肌肉痙攣，按應用，2021-2030 年（百萬美元）
表 605 新加坡醫用大麻市場噁心症狀（依應用），2021-2030 年（百萬美元）
表 606 新加坡醫用大麻市場需求損失（按應用劃分），2021 年至 2030 年（百萬美元）
表 607 新加坡醫用大麻市場中的飲食失調，按應用，2021-2030 年（百萬美元）
表 608 新加坡醫用大麻市場的發炎性腸道疾病，依應用，2021-2030 年（百萬美元）
表 609 新加坡醫用大麻市場的癌症，按應用，2021-2030 年（百萬美元）
表 610 新加坡醫用大麻市場中的關節炎藥物，按應用，2021-2030 年（百萬美元）
表 611 新加坡醫用大麻市場的消瘦症候群（惡病質）應用，2021-2030 年（百萬美元）
表612新加坡阿茲海默症醫用大麻市場，依應用，2021-2030年（百萬美元）
表613 新加坡醫用大麻市場的癲癇疾病，依應用，2021-2030年（百萬美元）
表 614 新加坡醫用大麻市場憂鬱症與睡眠障礙（按應用），2021-2030 年（百萬美元）
表615新加坡醫用大麻市場中的多發性硬化症，依應用，2021-2030年（百萬美元）
表 616 新加坡醫用大麻市場自閉症，依應用，2021-2030 年（百萬美元）
表 617 新加坡醫用大麻市場的精神健康狀況（按類型），2021-2030 年（百萬美元）
表 618 新加坡醫用大麻市場的精神健康狀況（按產品），2021-2030 年（百萬美元）
表 619 新加坡醫用大麻市場提升情緒，按應用，2021-2030 年（百萬美元）
表 620 新加坡醫用大麻市場，依管理途徑，2021-2030 年（百萬美元）
表 621 新加坡醫用大麻市場，依治療類型，2021-2030 年（百萬美元）
表 622 新加坡醫用大麻市場，按最終用戶，2021-2030 年（百萬美元）
表 623 新加坡醫用大麻市場，依分銷管道，2021-2030 年（百萬美元）
表 624 新加坡醫用大麻市場 B2C，依分銷管道，2021-2030 年（百萬美元）
表 625 印度醫用大麻市場，依產品，2021-2030 年（百萬美元）
表 626 印度醫用大麻市場石油（按類型），2021-2030 年（百萬美元）
表 627 印度醫用大麻市場石油，依來源，2021-2030 年（百萬美元）
表 628 印度醫用大麻市場石油，依種類，2021-2030 年（百萬美元）
表 629 印度醫用大麻油市場，依產品類型，2021-2030 年（百萬美元）
表 630 印度醫用大麻市場品牌，依產品類型，2021-2030 年（百萬美元）
表631印度醫用大麻市場乾燥醫用大麻，依產品，2021-2030（百萬美元）
表632 印度醫用大麻市場中的醫用大麻膠囊，按類型，2021-2030（百萬美元）
表633 印度醫用大麻市場中的醫用大麻膠囊，按濃縮物，2021-2030年（百萬美元）
表634 印度醫用大麻市場中的醫用大麻膠囊，依種類，2021-2030（百萬美元）
表635印度醫用大麻市場中的醫用大麻膠囊，依產品類型，2021-2030年（百萬美元）
表 636 印度醫用大麻市場品牌，依產品類型，2021-2030 年（百萬美元）
表 637 印度醫用大麻市場中的 VAPE PEN，按種類，2021-2030 年（百萬美元）
表 638 印度醫用大麻市場中的 VAPE PEN，依產品類型，2021-2030 年（百萬美元）
表 639 印度醫用大麻市場品牌，依產品類型，2021-2030 年（百萬美元）
表640印度醫用大麻全花市場，依品種，2021-2030年（百萬美元）
表641印度醫用大麻全花市場，依產品類型，2021-2030年（百萬美元）
表 642 印度醫用大麻市場品牌，依產品類型，2021-2030 年（百萬美元）
表643 印度醫用大麻市場中的乳霜和保濕霜，依種類，2021-2030年（百萬美元）
表644 印度醫用大麻市場中的乳霜和保濕霜，依產品類型，2021-2030年（百萬美元）
表 645 印度醫用大麻市場品牌，依產品類型，2021-2030 年（百萬美元）
表 646 印度醫用大麻市場地花，依品種，2021-2030 年（百萬美元）
表 647 印度醫用大麻市場地花，依產品類型，2021-2030 年（百萬美元）
表 648 印度醫用大麻市場品牌，依產品類型，2021-2030 年（百萬美元）
表 649 印度醫用大麻市場貼片，按類型，2021-2030 年（百萬美元）
表 650 印度醫用大麻市場貼片，依種類，2021-2030 年（百萬美元）
表 651 印度醫用大麻貼片市場，依產品類型，2021-2030 年（百萬美元）
表 652 印度醫用大麻市場品牌，依產品類型，2021-2030 年（百萬美元）
表653 印度醫用大麻市場中的面膜和精華液，依種類，2021-2030年（百萬美元）
表654 印度醫用大麻市場中的面膜和精華液，依產品類型，2021-2030年（百萬美元）
表 655 印度醫用大麻市場品牌，依產品類型，2021-2030 年（百萬美元）
表656 印度醫用大麻清潔劑市場，依種類，2021-2030（百萬美元）
表657 印度醫用大麻清潔劑市場，依產品類型，2021-2030年（百萬美元）
表 658 印度醫用大麻市場品牌，依產品類型，2021-2030 年（百萬美元）
表 659 印度醫用大麻市場，依來源，2021-2030 年（百萬美元）
表 660 印度醫用大麻合成市場，依來源，2021-2030 年（百萬美元）
表 661 印度醫用大麻市場，依種類，2021-2030 年（百萬美元）
表 662 印度醫用大麻市場（按衍生性商品劃分），2021-2030 年（百萬美元）
表 663 印度醫用大麻市場，按應用，2021-2030 年（百萬美元）
表 664 印度醫用大麻市場疼痛管理（按類型），2021-2030 年（百萬美元）
表 665 印度醫用大麻市場疼痛管理，依產品，2021-2030 年（百萬美元）
TABLE 666 INDIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 667 INDIA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 668 INDIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 669 INDIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 670 INDIA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 671 INDIA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 672 INDIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 673 INDIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 674 INDIA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 675 INDIA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 676 INDIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 677 INDIA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 678 INDIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 679 INDIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 680 INDIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 681 INDIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 682 INDIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 683 INDIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 684 INDIA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 685 INDIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 686 INDIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 687 INDIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 688 TAIWAN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 689 TAIWAN OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 690 TAIWAN OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 691 TAIWAN OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 692 TAIWAN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 693 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 694 TAIWAN DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 695 TAIWAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 696 TAIWAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 697 TAIWAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 698 TAIWAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 699 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 700 TAIWAN VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 701 TAIWAN VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 702 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 703 TAIWAN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 704 TAIWAN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 705 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 706 TAIWAN CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 707 TAIWAN CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 708 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 709 TAIWAN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 710 TAIWAN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 711 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 712 TAIWAN PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 713 TAIWAN PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 714 TAIWAN PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 715 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 716 TAIWAN MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 717 TAIWAN MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 718 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 719 TAIWAN CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 720 TAIWAN CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 721 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 722 TAIWAN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 723 TAIWAN SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 724 TAIWAN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 725 TAIWAN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 726 TAIWAN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 727 TAIWAN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 728 TAIWAN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 729 TAIWAN ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 730 TAIWAN MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 731 TAIWAN NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 732 TAIWAN APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 733 TAIWAN EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 734 TAIWAN INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 735 TAIWAN CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 736 TAIWAN ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 737 TAIWAN WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 738 TAIWAN ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 739 TAIWAN EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 740 TAIWAN DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 741 TAIWAN MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 742 TAIWAN AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 743 TAIWAN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 744 TAIWAN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 745 TAIWAN ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 746 TAIWAN MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 747 TAIWAN MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 748 TAIWAN MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 749 TAIWAN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 750 TAIWAN B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 751 MALAYSIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 752 MALAYSIA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 753 MALAYSIA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 754 MALAYSIA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 755 MALAYSIA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 756 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 757 MALAYSIA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 758 MALAYSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 759 MALAYSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 760 MALAYSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 761 MALAYSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 762 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 763 MALAYSIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 764 MALAYSIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 765 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 766 MALAYSIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 767 MALAYSIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 768 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 769 MALAYSIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 770 MALAYSIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 771 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 772 MALAYSIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 773 MALAYSIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 774 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 775 MALAYSIA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 776 MALAYSIA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 777 MALAYSIA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 778 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 779 MALAYSIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 780 MALAYSIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 781 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 782 MALAYSIA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 783 MALAYSIA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 784 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 785 MALAYSIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 786 MALAYSIA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 787 MALAYSIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 788 MALAYSIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 789 MALAYSIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 790 MALAYSIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
表791 馬來西亞醫用大麻市場疼痛管理，依產品，2021-2030年（百萬美元）
表 792 馬來西亞醫用大麻市場焦慮狀況，依應用，2021-2030 年（百萬美元）
表793 馬來西亞醫用大麻市場中的肌肉痙攣，按應用，2021-2030年（百萬美元）
表 794 馬來西亞醫用大麻市場噁心症狀，依應用，2021-2030 年（百萬美元）
表 795 馬來西亞醫用大麻市場需求損失（按應用劃分），2021 年至 2030 年（百萬美元）
表796 馬來西亞醫用大麻市場中的飲食失調，依應用，2021-2030年（百萬美元）
表797 馬來西亞醫用大麻市場中的發炎性腸道疾病，依應用，2021-2030年（百萬美元）
表798馬來西亞醫用大麻市場中的癌症，按應用，2021-2030年（百萬美元）
表799 馬來西亞醫用大麻市場中的關節炎，按應用，2021-2030年（百萬美元）
表800馬來西亞醫用大麻市場中的消瘦綜合症（惡病質），按應用，2021-2030年（百萬美元）
表801 馬來西亞阿茲海默症醫用大麻市場，依應用，2021-2030年（百萬美元）
表802 馬來西亞醫用大麻市場中的癲癇，按應用，2021-2030年（百萬美元）
表803 馬來西亞醫用大麻市場憂鬱症與睡眠障礙，依應用，2021-2030年（百萬美元）
表804 馬來西亞醫用大麻市場中的多發性硬化症，依應用，2021-2030年（百萬美元）
表805 馬來西亞醫用大麻市場自閉症，依應用，2021-2030年（百萬美元）
表806 馬來西亞醫用大麻市場的精神健康狀況，依類型，2021-2030年（百萬美元）
表807 馬來西亞醫用大麻市場的精神健康狀況，依產品，2021-2030年（百萬美元）
表808 馬來西亞醫用大麻市場提升情緒，依應用，2021-2030年（百萬美元）
表809 馬來西亞醫用大麻市場，依管理途徑，2021-2030年（百萬美元）
表810馬來西亞醫用大麻市場，依治療類型，2021-2030年（百萬美元）
表811 馬來西亞醫用大麻市場，依最終用戶，2021-2030年（百萬美元）
表812 馬來西亞醫用大麻市場，依通路，2021-2030年（百萬美元）
表813 馬來西亞醫用大麻市場B2C，依分銷管道，2021-2030年（百萬美元）
表814菲律賓醫用大麻市場，依產品，2021-2030（百萬美元）
表815菲律賓醫用大麻市場石油，按類型，2021-2030年（百萬美元）
表816菲律賓醫用大麻市場石油，依來源，2021-2030年（百萬美元）
表817菲律賓醫用大麻市場石油，依品種，2021-2030年（百萬美元）
表818菲律賓醫用大麻油市場，依產品類型，2021-2030年（百萬美元）
表819菲律賓醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表820菲律賓醫用大麻市場乾醫用大麻，依產品，2021-2030（百萬美元）
表821菲律賓醫用大麻市場中的醫用大麻膠囊，按類型，2021-2030（百萬美元）
表822菲律賓醫用大麻市場中的醫用大麻膠囊，依濃縮物，2021-2030年（百萬美元）
表823 菲律賓醫用大麻市場中的醫用大麻膠囊，依種類，2021-2030（百萬美元）
表824菲律賓醫用大麻市場醫用大麻膠囊，依產品類型，2021-2030（百萬美元）
表825菲律賓醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表826菲律賓醫用大麻市場中的VAPE筆，依種類，2021-2030（百萬美元）
表827菲律賓醫用大麻市場中的VAPE筆，依產品類型，2021-2030（百萬美元）
表828菲律賓醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表829菲律賓醫用大麻全花市場，依品種，2021-2030年（百萬美元）
表830菲律賓醫用大麻全花市場，依產品類型，2021-2030年（百萬美元）
表831菲律賓醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表832菲律賓醫用大麻乳霜及保濕霜市場，依種類，2021-2030（百萬美元）
表833 菲律賓醫用大麻乳霜及保濕霜市場（依產品種類），2021-2030年（百萬美元）
表834 菲律賓醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表835菲律賓醫用大麻市場地花，依品種，2021-2030年（百萬美元）
表836菲律賓醫用大麻市場地花，依產品類型，2021-2030年（百萬美元）
表837 菲律賓醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表838菲律賓醫用大麻市場貼片，按類型，2021-2030年（百萬美元）
表839菲律賓醫用大麻市場貼片，依種類，2021-2030年（百萬美元）
表840菲律賓醫用大麻市場貼片，依產品類型，2021-2030年（百萬美元）
表841菲律賓醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表842菲律賓醫用大麻麵膜和精華液市場，依種類，2021-2030（百萬美元）
表843 菲律賓醫用大麻麵膜和精華液市場（按產品類型），2021-2030年（百萬美元）
表844 菲律賓醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表845菲律賓醫用大麻清潔劑市場，依種類，2021-2030（百萬美元）
表846菲律賓醫用大麻清潔劑市場，依產品類型，2021-2030年（百萬美元）
表847 菲律賓醫用大麻市場品牌，依產品類型，2021-2030年（百萬美元）
表848菲律賓醫用大麻市場，依來源，2021-2030（百萬美元）
表849菲律賓醫用大麻合成市場，依來源，2021-2030年（百萬美元）
表850菲律賓醫用大麻市場，依種類，2021-2030年（百萬美元）
表851菲律賓醫用大麻市場，依衍生性商品，2021-2030年（百萬美元）
表852菲律賓醫用大麻市場，按應用，2021-2030（百萬美元）
表853 菲律賓醫用大麻市場疼痛管理（按類型），2021-2030年（百萬美元）
表854 菲律賓醫用大麻市場疼痛管理，依產品，2021-2030年（百萬美元）
表855菲律賓醫用大麻市場焦慮，按應用，2021-2030年（百萬美元）
表856菲律賓醫用大麻市場的肌肉痙攣，依應用，2021-2030年（百萬美元）
表857菲律賓醫用大麻市場噁心，依應用，2021-2030年（百萬美元）
表858菲律賓醫用大麻市場需求損失（按應用劃分），2021-2030年（百萬美元）
表859菲律賓醫用大麻市場中的飲食失調，依應用，2021-2030年（百萬美元）
表860菲律賓醫用大麻市場發炎性腸道疾病，依應用，2021-2030年（百萬美元）
表861菲律賓醫用大麻市場癌症應用狀況，2021-2030年（百萬美元）
表862菲律賓醫用大麻市場中的關節炎，按應用，2021-2030（百萬美元）
表863 菲律賓醫用大麻市場的消瘦症候群（惡病質）應用，2021-2030年（百萬美元）
表864 菲律賓阿茲海默症醫用大麻市場，依應用，2021-2030年（百萬美元）
表865菲律賓醫用大麻市場中的癲癇，按應用，2021-2030年（百萬美元）
表866菲律賓醫用大麻市場憂鬱症與睡眠障礙，依應用，2021-2030年（百萬美元）
表867菲律賓醫用大麻市場多發性硬化症，依應用，2021-2030年（百萬美元）
表868菲律賓醫用大麻市場自閉症，按應用，2021-2030年（百萬美元）
表869菲律賓醫用大麻市場的精神健康狀況，依類型，2021-2030年（百萬美元）
表870菲律賓醫用大麻市場的精神健康狀況，依產品，2021-2030年（百萬美元）
表871菲律賓醫用大麻市場提升情緒，按應用，2021-2030年（百萬美元）
表872 菲律賓醫用大麻市場，依給藥途徑，2021-2030年（百萬美元）
表873 菲律賓醫用大麻市場，依治療類型，2021-2030年（百萬美元）
表874 菲律賓醫用大麻市場，依最終用戶，2021-2030年（百萬美元）
表875菲律賓醫用大麻市場，依分銷管道，2021-2030年（百萬美元）
表876菲律賓醫用大麻市場B2C，依分銷管道，2021-2030年（百萬美元）
表877 亞太其他地區醫用大麻市場（依產品），2021-2030年（百萬美元）
图片列表
圖 1 亞太醫用大麻市場：細分
圖 2 亞太醫用大麻市場：數據三角測量
圖 3 亞太醫用大麻市場：DROC 分析
圖 4 亞太醫用大麻市場：亞太地區與區域市場分析
圖 5 亞太醫用大麻市場：公司研究分析
圖 6 亞太醫用大麻市場：訪談人口統計
圖 7 亞太醫用大麻市場：DBMR 市場地位網格
圖 8 亞太醫用大麻市場：市場應用覆蓋範圍
圖 9 亞太醫用大麻市場：供應商份額分析
圖 10 亞太醫用大麻市場：細分
圖 11 預計醫用大麻的不斷增長和合法化將在 2023 年至 2030 年預測期內推動亞太醫用大麻市場的發展
圖 12 預計該產品細分市場將在 2023 年和 2030 年佔據亞太醫用大麻市場的最大份額
圖 13 亞太醫用大麻市場的驅動因素、限制因素、機會與挑戰
圖 14 亞太醫用大麻市場：依產品劃分，2022 年
圖 15 亞太醫用大麻市場：依產品劃分，2023-2030 年（百萬美元）
圖 16 亞太醫用大麻市場：依產品劃分，複合年增長率（2023-2030 年）
圖 17 亞太醫用大麻市場：依產品、生命線曲線
圖 18 亞太醫用大麻市場：依品種劃分，2022 年
圖 19 亞太醫用大麻市場：依品種，2023-2030 年（百萬美元）
圖 20 亞太醫用大麻市場：依種類、複合年增長率（2023-2030 年）
圖 21 亞太醫用大麻市場：依品種、生命線曲線
圖 22 亞太醫用大麻市場：依衍生性商品劃分，2022 年
圖 23 亞太醫用大麻市場：依衍生性商品劃分，2023-2030 年（百萬美元）
圖 24 亞太醫用大麻市場：依衍生性商品劃分，複合年增長率（2023-2030 年）
圖 25 亞太醫用大麻市場：依衍生性商品、生命線曲線
圖 26 亞太醫用大麻市場：按應用，2022 年
圖 27 亞太醫用大麻市場：按應用，2023-2030 年（百萬美元）
圖 28 亞太醫用大麻市場：依應用、複合年增長率（2023-2030 年）
圖 29 亞太醫用大麻市場：按應用、生命線曲線
圖 30 亞太醫用大麻市場：依給藥途徑，2022 年
圖 31 亞太醫用大麻市場：依給藥途徑，2023-2030 年（百萬美元）
圖 32 亞太醫用大麻市場：依給藥途徑、複合年增長率（2023-2030 年）
圖 33 亞太醫用大麻市場：依給藥途徑、生命線曲線
圖 34 亞太醫用大麻市場：依治療類型，2022 年
圖 35 亞太醫用大麻市場：依治療類型，2023-2030 年（百萬美元）
圖 36 亞太醫用大麻市場：依治療類型、複合年增長率（2023-2030 年）
圖 37 亞太醫用大麻市場：依治療類型、生命線曲線
圖 38 亞太醫用大麻市場：依最終用戶劃分，2022 年
圖 39 亞太醫用大麻市場：按最終用戶劃分，2023-2030 年（百萬美元）
圖 40 亞太醫用大麻市場：依最終用戶、複合年增長率（2023-2030 年）
圖 41 亞太醫用大麻市場：依最終用戶、生命線曲線
圖 42 亞太醫用大麻市場：依通路劃分，2022 年
圖 43 亞太醫用大麻市場：按分銷管道，2023-2030 年（百萬美元）
圖 44 亞太醫用大麻市場：依分銷管道、複合年增長率（2023-2030 年）
圖 45 亞太醫用大麻市場：按分銷管道、生命線曲線
圖 46 亞太醫用大麻市場：快照（2022 年）
圖 47 亞太醫用大麻市場：按國家劃分（2022 年）
圖 48 亞太醫用大麻市場：按國家劃分（2023 年和 2030 年）
圖 49 亞太醫用大麻市場：按國家劃分（2022 年和 2030 年）
圖 50 亞太醫用大麻市場：依產品（2023-2030 年）
圖51 亞太醫用大麻市場：2022年公司佔有率（%）
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
